Earli was founded by Dr. Sam Gambhir, Cyriac Roeding, Dr. David Suhy in 2018.

Who are Earli's investors?

Earli's investors include Alumni Ventures, Andreessen Horowitz, Blue Ivy Ventures, Breyer Capital, Gaingels, Han River Partners, IKJ Capital, Ligo Partners LLC and 5 more.

How much funding has Earli raised?

Earli has disclosed $40M raised across 1 round.

Where is Earli headquartered?

Earli is headquartered in South San Francisco, US.

Earli

South San Francisco, US · Founded 2018 · Delaware corporation · 37 employees on LinkedIn · 13 known investors

Find your way into Earli

Paths you didn't know you had: your email and LinkedIn already hold routes to the Earli team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells. The company focuses on oncology diagnostics and therapeutics for cancer patients.

AI & Machine Learning Biotech Deep Tech Healthtech Medical Devices

Founders & leadership

Earli was founded in 2018 by Dr. Sam Gambhir, Cyriac Roeding, and Dr. David Suhy.

Dr. Sam GambhirFounder

Cyriac Roeding Founder

Dr. David SuhyCo-founder & Chief Scientific Officer

Board

Justin Kao Board directorPartner at DFJ

Jorge Conde Board directorGeneral Partner at Andreessen Horowitz

Investors · 13

Alumni Ventureslisted by Alumni VenturesManchester · $100K – $10M

How we know: av.vc · Not right? Tell us

Andreessen Horowitzlisted by Andreessen HorowitzMenlo Park · $500K – $50Mvia Jorge Conde · board

How we know: a16z's portfolio · board seat on SEC Form D · Not right? Tell us

Blue Ivy Ventureslisted by Blue Ivy VenturesBoston

How we know: Blue Ivy Ventures's portfolio page · Not right? Tell us

Breyer Capitallisted by Breyer CapitalAustin · $500K – $10M

How we know: Breyer Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Gaingelslisted by GaingelsNew York · $200K – $500K

How we know: gaingels.com · Not right? Tell us

Han River Partnerslisted by Han River PartnersMenlo Park

How we know: Han River Partners's portfolio page · Not right? Tell us

IKJ Capitallisted by IKJ CapitalPalo Alto

How we know: IKJ Capital's portfolio page · Not right? Tell us

Ligo Partners LLClisted by Ligo Partners LLCMiami

How we know: Ligo Partners LLC's portfolio page · Not right? Tell us

Menlo Ventureslisted by Menlo VenturesSan Francisco · $1M – $20M

How we know: Menlo Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

WSSlisted by WSS

DFJinferredSan Mateovia Justin Kao · board

How we know: board seat on SEC Form D · Not right? Tell us

Khosla VenturesreportedMenlo Park · $100K – $20M

How we know: a partner's Signal profile · Not right? Tell us

MBX CapitalreportedClaymont · $250K – $2.5M

How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$40M disclosed across 1 round · 2021

▶$40MraisedJan 2021 · 20 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Justin KaoDirector
Jorge CondeDirector
Cyriac RoedingExecutive Officer, Director
David SuhyExecutive Officer, Director

Offering amount: $40M
Amount sold: $40M
First sale: Jan 2021
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Earli went on to found or lead other companies.

Justin KaoDirectorFounded Helix Cyriac RoedingFounderFounded Shopkick

Related companies · 3

Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Intellia TherapeuticsIntellia Therapeutics develops in vivo and ex vivo CRISPR/Cas9 gene editing therapies aimed at treating the root causes of severe genetic diseases, with lead candidates for hereditary angioedema and ATTR amyloidosis. The company operates as a clinical-stage biopharmaceutical company pursuing potentially curative treatments from discovery through commercialization.

Companies working in the same space as Earli.

Frequently asked questions

What does Earli do?: Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells. The company focuses on oncology diagnostics and therapeutics for cancer patients.
Who founded Earli?: Earli was founded by Dr. Sam Gambhir, Cyriac Roeding, Dr. David Suhy in 2018.
Who are Earli's investors?: Earli's investors include Alumni Ventures, Andreessen Horowitz, Blue Ivy Ventures, Breyer Capital, Gaingels, Han River Partners, IKJ Capital, Ligo Partners LLC and 5 more.
How much funding has Earli raised?: Earli has disclosed $40M raised across 1 round.
Where is Earli headquartered?: Earli is headquartered in South San Francisco, US.